EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans
Nature Medicine2012Vol. 18(9), pp. 1418–1422
Citations Over TimeTop 1% of 2012 papers
Annelies Van Hoecke, Lies Schoonaert, Robin Lemmens, Mieke Timmers, Kim A. Staats, Angela S. Laird, Elke Peeters, Thomas Philips, An Goris, Bénédicte Dubois, Peter M. Andersen, Ammar Al‐Chalabi, Vincent Thijs, Ann M. Turnley, Paul W van Vught, Jan H. Veldink, Orla Hardiman, Ludo Van Den Bosch, Paloma González-Pérez, Philip Van Damme, Robert H. Brown, Leonard H. van den Berg, Wim Robberecht
Related Papers
- → Is SOD1 loss of function involved in amyotrophic lateral sclerosis?(2013)318 cited
- → Perspective on SOD1 mediated toxicity in Amyotrophic Lateral Sclerosis(2016)32 cited
- → Expression of the copper‐zinc superoxide dismutase gene in amyotrophic lateral sclerosis(1997)6 cited
- Cu,Zn-superoxide Dismutase Associated with Amyotrophic Lateral Sclerosis(2008)
- Progress in the relationship between mutant SOD1 and amyotrophic lateral sclerosis.(2009)